Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin
BACKGROUND: The treatment of neuropathic pain continues to be difficult. Randomized, controlled trials (RCTs) provide some evidence to guide therapy. Most data relate to antidepressant therapy, although there is information on anticonvulsants and other treatments. Mistaken beliefs about many of thes...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/1999/961273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567069787291648 |
|---|---|
| author | C Peter N Watson Judith H Watt-Watson |
| author_facet | C Peter N Watson Judith H Watt-Watson |
| author_sort | C Peter N Watson |
| collection | DOAJ |
| description | BACKGROUND: The treatment of neuropathic pain continues to be difficult. Randomized, controlled trials (RCTs) provide some evidence to guide therapy. Most data relate to antidepressant therapy, although there is information on anticonvulsants and other treatments. Mistaken beliefs about many of these treatments are prevalent and need to be dispelled. Opioids are increasingly being used for the refractory patient. There has been recent enthusiasm for the anticonvulsant gabapentin for the treatment of these conditions. |
| format | Article |
| id | doaj-art-ee618a32152644749429af7ff0968836 |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 1999-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-ee618a32152644749429af7ff09688362025-02-03T01:02:29ZengWileyPain Research and Management1203-67651999-01-014416817810.1155/1999/961273Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and GabapentinC Peter N Watson0Judith H Watt-Watson1Department of Medicine, University of Toronto, Toronto, Ontario, CanadaFaculty of Nursing, University of Toronto, Toronto, Ontario, CanadaBACKGROUND: The treatment of neuropathic pain continues to be difficult. Randomized, controlled trials (RCTs) provide some evidence to guide therapy. Most data relate to antidepressant therapy, although there is information on anticonvulsants and other treatments. Mistaken beliefs about many of these treatments are prevalent and need to be dispelled. Opioids are increasingly being used for the refractory patient. There has been recent enthusiasm for the anticonvulsant gabapentin for the treatment of these conditions.http://dx.doi.org/10.1155/1999/961273 |
| spellingShingle | C Peter N Watson Judith H Watt-Watson Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin Pain Research and Management |
| title | Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin |
| title_full | Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin |
| title_fullStr | Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin |
| title_full_unstemmed | Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin |
| title_short | Treatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin |
| title_sort | treatment of neuropathic pain focus on antidepressants opioids and gabapentin |
| url | http://dx.doi.org/10.1155/1999/961273 |
| work_keys_str_mv | AT cpeternwatson treatmentofneuropathicpainfocusonantidepressantsopioidsandgabapentin AT judithhwattwatson treatmentofneuropathicpainfocusonantidepressantsopioidsandgabapentin |